Evidence map›Paper›PMID 39222190›Full record

ReviewJournal of neuro-oncology2024

Endovascular surgical neuro-oncology: advancing a new subspecialty.

Christopher C Young, Peter Kan, Stephen R Chen, Frederick F Lang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neuro-oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher C YoungDepartment of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Peter KanDepartment of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stephen R ChenDepartment of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Frederick F LangDepartment of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA. flang@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endovascular surgical neuro-oncology is a relatively new subspecialty which uses endovascular neuro-interventional techniques for the management of nervous system tumors and tumor-related vascular conditions. Although there are several endovascular procedures that are widely available as standard-of-care diagnostic and treatment adjuncts, there has been a renewed interest to explore endovascular approaches as a means for selective intra-arterial delivery of therapeutic agents to nervous system tumors, including methods for opening the blood brain and blood tumor barriers. In this review, we discuss the historical development of various forms of endovascular intra-arterial treatment for tumors over the past 40 years, summarize endovascular approaches that are currently being employed, and highlight current clinical trials.

Indexed as

Brain NeoplasmsEndovascular ProceduresHumansSurgical OncologyEndovascular neuro-oncologyImmunotherapyIntra-arterial infusionOncolytic virusTransarterial chemo-embolizationTumor embolizationTumor infusion

Identifiers

PMID39222190

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.